Wells Fargo Maintains Equal-Weight on Conmed, Raises Price Target to $46
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
Wells Fargo analyst Larry Biegelsen maintains Conmed (NYSE:CNMD) with a Equal-Weight and raises the price target from $39 to $46.
Wells Fargo analyst Larry Biegelsen maintains Conmed (NYSE:CNMD) with a Equal-Weight and raises the price target from $39 to $46.